| Nome |
# |
|
The role of insulin resistance in nonalcoholic steatohepatitis and liver disease development : a potential therapeutic target?, file dfa8b995-cbf5-748b-e053-3a05fe0a3a96
|
641
|
|
Statin use and nonalcoholic steatohepatitis in at risk individuals, file dfa8b992-82dc-748b-e053-3a05fe0a3a96
|
564
|
|
PNPLA3 I148M polymorphism and progressive liver disease, file dfa8b991-8293-748b-e053-3a05fe0a3a96
|
398
|
|
Serum coding and non-coding RNAs as biomarkers of NAFLD and fibrosis severity, file dfa8b99e-c322-748b-e053-3a05fe0a3a96
|
330
|
|
Prevalence and Risk Factors of Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Without Steatohepatitis, file dfa8b9a0-cd74-748b-e053-3a05fe0a3a96
|
258
|
|
PNPLA3 I148M Polymorphism, Clinical Presentation, and Survival in Patients with Hepatocellular Carcinoma, file dfa8b991-00e6-748b-e053-3a05fe0a3a96
|
253
|
|
A Nutrigenomic Approach to Non-Alcoholic Fatty Liver Disease, file dfa8b99c-a654-748b-e053-3a05fe0a3a96
|
245
|
|
Genetic factors in the pathogenesis of nonalcoholic fatty liver and steatohepatitis, file dfa8b995-bc6a-748b-e053-3a05fe0a3a96
|
228
|
|
MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individuals, file dfa8b99a-82c4-748b-e053-3a05fe0a3a96
|
223
|
|
Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver, file dfa8b99d-06c9-748b-e053-3a05fe0a3a96
|
221
|
|
The A736V TMPRSS6 Polymorphism Influences Hepatic Iron Overload in Nonalcoholic Fatty Liver Disease, file dfa8b98f-0b48-748b-e053-3a05fe0a3a96
|
215
|
|
Renin-Angiotensin System Inhibitors, Type 2 Diabetes and Fibrosis Progression : An Observational Study in Patients with Nonalcoholic Fatty Liver Disease, file dfa8b996-37c7-748b-e053-3a05fe0a3a96
|
203
|
|
Epicardial Adipose Tissue (EAT) thickness is associated with cardiovascular and liver damage in nonalcoholic fatty liver disease, file dfa8b996-7d95-748b-e053-3a05fe0a3a96
|
190
|
|
β-Klotho gene variation is associated with liver damage in children with NAFLD, file dfa8b9a0-e0be-748b-e053-3a05fe0a3a96
|
178
|
|
A novel alpha1-antitrypsin null variant (PiQ0Milano), file dfa8b991-0084-748b-e053-3a05fe0a3a96
|
172
|
|
High fat diet subverts hepatocellular iron uptake determining dysmetabolic iron overload, file dfa8b992-12ba-748b-e053-3a05fe0a3a96
|
172
|
|
The i148m Pnpla3 polymorphism influences serum adiponectin in patients with fatty liver and healthy controls, file dfa8b990-6bd2-748b-e053-3a05fe0a3a96
|
167
|
|
Alcohol or gut microbiota : who is the guilty?, file dfa8b9a2-e9b4-748b-e053-3a05fe0a3a96
|
165
|
|
MBOAT7 down-regulation by genetic and environmental factors predisposes to MAFLD, file dfa8b9a2-cb20-748b-e053-3a05fe0a3a96
|
150
|
|
Liver transcriptomics highlights interleukin-32 as novel NAFLD-related cytokine and candidate biomarker, file dfa8b9a1-4096-748b-e053-3a05fe0a3a96
|
149
|
|
Interaction between PNPLA3 I148M variant and age at infection in determining fibrosis progression in chronic hepatitis C, file dfa8b991-908c-748b-e053-3a05fe0a3a96
|
148
|
|
MAFLD in COVID-19 patients: an insidious enemy, file dfa8b9a4-bfbe-748b-e053-3a05fe0a3a96
|
146
|
|
The A736V TMPRSS6 polymorphism influences hepcidin and iron metabolism in chronic hemodialysis patients : TMPRSS6 and hepcidin in hemodialysis, file dfa8b990-fa3e-748b-e053-3a05fe0a3a96
|
144
|
|
Genetic and metabolic factors: the perfect combination to treat metabolic associated fatty liver disease, file dfa8b9a4-db41-748b-e053-3a05fe0a3a96
|
141
|
|
Rare Pathogenic Variants Predispose to Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease, file dfa8b99e-af7c-748b-e053-3a05fe0a3a96
|
140
|
|
Lack of association between peroxisome proliferator-activated receptors alpha and gamma2 polymorphisms and progressive liver damage in patients with non-alcoholic fatty liver disease: a case control study, file dfa8b996-19eb-748b-e053-3a05fe0a3a96
|
134
|
|
Telomerase reverse transcriptase germline mutations and hepatocellular carcinoma in patients with nonalcoholic fatty liver disease, file dfa8b99a-8ed7-748b-e053-3a05fe0a3a96
|
133
|
|
Macrophage MerTK Promotes Liver Fibrosis in Nonalcoholic Steatohepatitis, file dfa8b9a1-9a26-748b-e053-3a05fe0a3a96
|
132
|
|
Protein phosphatase 1 regulatory subunit 3B gene variation protects against hepatic fat accumulation and fibrosis in individuals at high risk of nonalcoholic fatty liver disease, file dfa8b99c-eb37-748b-e053-3a05fe0a3a96
|
131
|
|
The TM6SF2 E167K genetic variant induces lipid biosynthesis and reduces apolipoprotein B secretion in human hepatic 3D spheroids, file dfa8b9a1-0c00-748b-e053-3a05fe0a3a96
|
130
|
|
HFE mutations modulate the effect of iron on serum hepcidin-25 in chronic hemodialysis patients, file dfa8b99b-fdca-748b-e053-3a05fe0a3a96
|
127
|
|
Peroxisome proliferator-activated receptor genetic polymorphisms and nonalcoholic fatty liver disease: Any role in disease susceptibility?, file dfa8b991-8543-748b-e053-3a05fe0a3a96
|
124
|
|
FGF23 and Fetuin-A interaction in the liver and in the circulation, file dfa8b99b-a743-748b-e053-3a05fe0a3a96
|
122
|
|
MiRNA signature in NAFLD: A turning point for a non-invasive diagnosis, file dfa8b99d-5607-748b-e053-3a05fe0a3a96
|
116
|
|
PCSK7 gene variation bridges atherogenic dyslipidemia with hepatic inflammation in NAFLD patients, file dfa8b99f-101d-748b-e053-3a05fe0a3a96
|
111
|
|
Iron stores, hepcidin, and aortic stiffness in individuals with hypertension, file dfa8b993-426a-748b-e053-3a05fe0a3a96
|
107
|
|
Remodeling of mitochondrial plasticity: The key switch from NAFLD/Nash to HCC, file dfa8b9a7-039f-748b-e053-3a05fe0a3a96
|
104
|
|
Recreating gut-liver axis during NAFLD onset by using a Caco-2/HepG2 co-culture system, file dfa8b9aa-7fab-748b-e053-3a05fe0a3a96
|
98
|
|
Mboat7 down-regulation by hyper-insulinemia induces fat accumulation in hepatocytes: Mboat7 reduction and hepatic steatosis, file dfa8b9a1-de53-748b-e053-3a05fe0a3a96
|
96
|
|
Serum ferritin levels are associated with vascular damage in patients with nonalcoholic fatty liver disease, file dfa8b990-fd8b-748b-e053-3a05fe0a3a96
|
84
|
|
Mir-101-3p downregulation promotes fibrogenesis by facilitating hepatic stellate cell transdifferentiation during insulin resistance, file dfa8b9a1-0299-748b-e053-3a05fe0a3a96
|
75
|
|
Nutrition and genetics in NAFLD : The perfect binomium, file dfa8b9a2-4c10-748b-e053-3a05fe0a3a96
|
75
|
|
From Environment to Genome and Back : a Lesson from HFE Mutations, file dfa8b9a2-5f7d-748b-e053-3a05fe0a3a96
|
70
|
|
TM6SF2/PNPLA3/MBOAT7 Loss-of-Function Genetic Variants Impact on NAFLD Development and Progression Both in Patients and in In Vitro Models, file 717439a1-30e7-4d8a-a9f9-551acd0d2d3b
|
69
|
|
The role of probiotics in nonalcoholic fatty liver disease : A new insight into therapeutic strategies, file dfa8b9a2-e02c-748b-e053-3a05fe0a3a96
|
63
|
|
Adipocyte PHLPP2 inhibition prevents obesity-induced fatty liver, file dfa8b9a8-0994-748b-e053-3a05fe0a3a96
|
63
|
|
The KLB rs17618244 gene variant is associated with fibrosing MAFLD by promoting hepatic stellate cell activation, file dfa8b9a7-ea99-748b-e053-3a05fe0a3a96
|
60
|
|
Genetics, immunity and nutrition boost the switching from nash to hcc, file dfa8b9a9-1d8e-748b-e053-3a05fe0a3a96
|
48
|
|
Rare ATG7 genetic variants predispose patients to severe fatty liver disease, file dfa8b9aa-636d-748b-e053-3a05fe0a3a96
|
48
|
|
$\upalpha$-Lipoic Acid Improves Hepatic Metabolic Dysfunctions in Acute Intermittent Porphyria: A Proof-of-Concept Study [alpha-Lipoic Acid Improves Hepatic Metabolic Dysfunctions in Acute Intermittent Porphyria: A Proof-of-Concept Study], file dfa8b9a9-a326-748b-e053-3a05fe0a3a96
|
43
|
|
Degradation of PHLPP2 by KCTD17, via a Glucagon-Dependent Pathway, Promotes Hepatic Steatosis, file dfa8b9a6-5c9b-748b-e053-3a05fe0a3a96
|
39
|
|
The α-Lipoic Acid Improves Hepatic Metabolic Dysfunctions in Acute Intermittent Porphyria: A Proof-of-Concept Study, file dfa8b9a9-a324-748b-e053-3a05fe0a3a96
|
38
|
|
Genetics is of the essence to face NAFLD, file dfa8b9aa-71d7-748b-e053-3a05fe0a3a96
|
38
|
|
Impact of Sarcopenia and Myosteatosis in Non-Cirrhotic Stages of Liver Diseases: Similarities and Differences across Aetiologies and Possible Therapeutic Strategies, file 852f28fa-227b-4052-b857-1753a2d18624
|
34
|
|
Expanding the phenotypic spectrum of non-alcoholic fatty liver disease and hypertriglyceridemia, file 9a028445-c39a-43b2-8eb2-7670fc7a71a8
|
32
|
|
Interaction between estrogen receptor-α and PNPLA3 p.I148M variant drives fatty liver disease susceptibility in women, file 389a87b3-6def-414f-8a27-5e36950f9234
|
28
|
|
Effluent molecular analysis guides liver graft allocation to clinical hypothermic oxygenated machine perfusion, file dfa8b9aa-42a6-748b-e053-3a05fe0a3a96
|
27
|
|
Salivary biomarkers: novel noninvasive tools to diagnose chronic inflammation, file 924f3c46-e3a3-4549-977a-148f0ef30afe
|
26
|
|
Circulating indian hedgehog is a marker of the hepatocyte-TAZ pathway in experimental NASH and is elevated in humans with NASH, file 79b1b3c6-4d2d-4488-aea4-cd221c113433
|
24
|
|
{PD}-1/{PD}-L1 Immuno-Mediated Therapy in {NAFLD}: Advantages and Obstacles in the Treatment of Advanced Disease, file c1df3a5f-e91b-4144-b438-f21bf45808e8
|
22
|
|
Interaction between lifestyle changes and PNPLA3 genotype in NAFLD patients during the COVID-19 lockdown, file f2c69dd4-82c1-4dc6-bd21-5bd5696e69a3
|
20
|
|
The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent, file dfa8b9a6-5a82-748b-e053-3a05fe0a3a96
|
19
|
|
The rs599839 a>g variant disentangles cardiovascular risk and hepatocellular carcinoma in nafld patients, file 77640ebc-2be0-4b63-bda7-3b8c0c029f11
|
16
|
|
The rs2294918 E434K variant modulates PNPLA3 expression and liver damage, file dfa8b994-ba5e-748b-e053-3a05fe0a3a96
|
16
|
|
Dietary iron overload induces visceral adipose tissue insulin resistance, file dfa8b991-2a6a-748b-e053-3a05fe0a3a96
|
15
|
|
Transmembrane 6 Superfamily Member 2 Gene Variant Disentangles Nonalcoholic Steatohepatitis From Cardiovascular Disease, file dfa8b994-d2be-748b-e053-3a05fe0a3a96
|
14
|
|
Effect of the A736V TMPRSS6 polymorphism on the penetrance and clinical expression of hereditary hemochromatosis, file dfa8b98f-06a4-748b-e053-3a05fe0a3a96
|
12
|
|
Increased insulin receptor substrate 2 expression is associated with steatohepatitis and altered lipid metabolism in obese subjects, file dfa8b98f-0a9c-748b-e053-3a05fe0a3a96
|
12
|
|
IL28B rs12979860 polymorphism influences serum TNFalpha levels in chronic hepatitis C, file dfa8b98f-3d12-748b-e053-3a05fe0a3a96
|
11
|
|
MERTK rs4374383 polymorphism affects the severity of fibrosis in non-alcoholic fatty liver disease, file dfa8b995-5b70-748b-e053-3a05fe0a3a96
|
11
|
|
Liver fat accumulation is associated with circulating PCSK9, file dfa8b995-6717-748b-e053-3a05fe0a3a96
|
11
|
|
Rare ATG7 genetic variants predispose patients to severe fatty liver disease, file 9b541703-0b27-418b-8d81-355bbc0eb20e
|
10
|
|
Diagnostic and therapeutic implications of the association between ferritin level and severity of nonalcoholic fatty liver disease, file dfa8b98f-1875-748b-e053-3a05fe0a3a96
|
10
|
|
Hepatic steatosis and PNPLA3 I148M variant are associated with serum Fetuin-A independently of insulin resistance, file dfa8b994-47b4-748b-e053-3a05fe0a3a96
|
10
|
|
The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent, file dfa8b995-60ce-748b-e053-3a05fe0a3a96
|
9
|
|
PNPLA3 overexpression results in reduction of proteins predisposing to fibrosis, file dfa8b9a0-6309-748b-e053-3a05fe0a3a96
|
9
|
|
The rs2294918 E434K variant modulates PNPLA3 expression and liver damage, file dfa8b994-fdd1-748b-e053-3a05fe0a3a96
|
8
|
|
Hepcidin resistance in dysmetabolic iron overload, file dfa8b995-9230-748b-e053-3a05fe0a3a96
|
8
|
|
Notch-mediated hepatocyte MCP-1 secretion causes liver fibrosis, file 636a09ca-69dc-42f7-a9bf-0e791a3e48e3
|
7
|
|
Transmembrane 6 superfamily member 2 gene E167K variant impacts on steatosis and liver damage in chronic hepatitis C patients, file dfa8b992-8424-748b-e053-3a05fe0a3a96
|
7
|
|
Increased circulating adiponectin in males with chronic HCV hepatitis, file dfa8b992-fe22-748b-e053-3a05fe0a3a96
|
7
|
|
T-ARMS-PCR for the evaluation of rs12979860 IL28B genotype : an optimized protocol, file dfa8b993-a1d0-748b-e053-3a05fe0a3a96
|
7
|
|
Statin use and nonalcoholic steatohepatitis in at risk individuals, file dfa8b994-81c3-748b-e053-3a05fe0a3a96
|
7
|
|
Particulate matter phagocytosis induces tissue factor in differentiating macrophages, file dfa8b992-90fd-748b-e053-3a05fe0a3a96
|
6
|
|
Particulate matter phagocytosis induces tissue factor in differentiating macrophages, file dfa8b99b-4d4b-748b-e053-3a05fe0a3a96
|
6
|
|
Lipid accumulation impairs lysosomal acid lipase activity in hepatocytes : evidence in NAFLD patients and cell cultures, file dfa8b99f-a626-748b-e053-3a05fe0a3a96
|
6
|
|
Liver transplantation for hepatocellular carcinoma in a patient with a novel telomerase mutation and steatosis, file dfa8b98f-48a7-748b-e053-3a05fe0a3a96
|
5
|
|
Transmembrane 6 superfamily member 2 gene E167K variant impacts on steatosis and liver damage in chronic hepatitis C patients, file dfa8b994-5610-748b-e053-3a05fe0a3a96
|
5
|
|
Interferon lambda 4 rs368234815 TT>δG variant is associated with liver damage in patients with nonalcoholic fatty liver disease, file dfa8b99a-b123-748b-e053-3a05fe0a3a96
|
5
|
|
Nutritional therapy for non-alcoholic fatty liver disease, file dfa8b99b-5382-748b-e053-3a05fe0a3a96
|
5
|
|
FibroScan Identifies Patients With Nonalcoholic Fatty Liver Disease and Cardiovascular Damage, file dfa8b9a1-fe0a-748b-e053-3a05fe0a3a96
|
5
|
|
Iron depletion by phlebotomy improves insulin resistance in patients with nonalcoholic fatty liver disease and hyperferritinemia : evidence from a case-control study, file dfa8b990-8625-748b-e053-3a05fe0a3a96
|
4
|
|
Iron and insulin resistance, file dfa8b990-8672-748b-e053-3a05fe0a3a96
|
4
|
|
Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity, file dfa8b99a-6053-748b-e053-3a05fe0a3a96
|
4
|
|
Impact of natural neuromedin-B receptor variants on iron metabolism, file dfa8b9a1-9cc7-748b-e053-3a05fe0a3a96
|
4
|
|
PCSK9 rs11591147 R46L Loss‐of‐Function Variant Protects Against Liver Damage in Individuals with NAFLD, file dfa8b9a4-d12f-748b-e053-3a05fe0a3a96
|
4
|
|
Bloodletting ameliorates insulin sensitivity and secretion in parallel to reducing liver iron in carriers of HFE gene mutations, file dfa8b990-8842-748b-e053-3a05fe0a3a96
|
3
|
|
Patatin-like phospholipase domain-containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis C, file dfa8b993-cd92-748b-e053-3a05fe0a3a96
|
3
|
|
A tetra-primer amplification refractory mutation system polymerase chain reaction for the evaluation of rs12979860 IL28B genotype, file dfa8b994-0c4f-748b-e053-3a05fe0a3a96
|
3
|
|
PNPLA3 I148M variant influences circulating retinol in adults with nonalcoholic fatty liver disease or obesity, file dfa8b995-c50b-748b-e053-3a05fe0a3a96
|
3
|
| Totale |
8.843 |